Offer in-store consultations with nutritionists : Provide personalized advice on GLP-1 friendly products through in-store consultations with nutritionists
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Those taking Eli Lilly's GLP-1 drug lost 25.5%
a digital twin) and uncover subtle, complex patterns (like, for example, how a specific sleep pattern interacts with a genetic marker to influence the GLP-1's effect)
While semaglutide is not currently restricted for people with dermatitis, doctors may still choose to watch these patients more closely, especially in the first few weeks or months after starting the drug
